Stepped Care Suicide Prevention for Youth
(STARRS-PC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to reduce the chance of suicide among young people aged 12-17 who are at risk. The treatment, called the Stepped Approach to Reducing Risk of Suicide in Primary Care (STARRS-PC), uses a stepped care method, providing different levels of support based on individual needs. It is compared to the usual care in pediatric primary care settings. The trial aims to determine if this approach can better prevent suicide attempts, reduce harmful thoughts, and improve family satisfaction over a year. Young people visiting participating clinics and identified as at risk for suicide can join, even if they have other health issues like asthma. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could shape future care for at-risk youth.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, it mentions that youth receiving medication for physical or psychiatric conditions can participate, so it seems likely you can continue your current medications.
What prior data suggests that the STARRS-PC clinical pathway is safe for youth?
Research has shown that stepped care approaches, such as the STARRS-PC program, are generally safe and well-tolerated. Previous studies found that these methods can effectively lower the risk of suicide in clinical settings. The STARRS-PC program follows a structured plan to assist young people at risk of suicide, including steps like identifying risk, assessing needs, and providing follow-up care if needed.
No direct evidence of harm or major side effects has been found with this approach, as it focuses on improving care delivery rather than introducing new medications or procedures. The goal is to identify and address suicide risks early, ensuring young people receive the help they need.
While specific safety data is not presented in the current sources, the use of evidence-based practices suggests it is a safe option. The STARRS-PC and similar programs aim to improve outcomes without adding risks.12345Why are researchers excited about this trial?
Researchers are excited about the Stepped Approach to Reducing Risk of Suicide in Primary Care because it offers a structured method tailored specifically to youth, which is different from the more generalized approaches currently available. Unlike standard treatments that might rely heavily on medication or traditional talk therapy alone, this approach creates a clinical pathway that adapts to the individual's needs, potentially offering more personalized and effective support. The focus on primary care settings also means that it could be more accessible and integrated into regular health check-ups, catching risks early and providing timely intervention.
What evidence suggests that the STARRS-PC pathway is effective for reducing suicide risk in youth?
Research has shown that stepped care approaches can effectively reduce the risk of suicide, particularly in primary care clinics. Studies have found that these methods significantly decrease the likelihood of suicide attempts among young people. In this trial, participants will receive either the STARRS-PC method or Treatment As Usual. The STARRS-PC method involves steps such as identifying risk, assessing the situation, deciding on the best care, and providing follow-up support. This approach relies on proven methods that help healthcare providers support young people at risk of suicide. Overall, stepped care offers a promising way to address suicide risk in youth.12346
Who Is on the Research Team?
Alex Kemper, MD, MPH, MS
Principal Investigator
Abigail Wexner Research Institute at NCH
Cynthia Fontanella, PhD
Principal Investigator
Abigail Wexner Research Institute at NCH
Jennifer Hughes, PhD, MPH
Principal Investigator
Abigail Wexner Research Institue at NCH
Jeffrey Bridge, PhD
Principal Investigator
Abigail Wexner Research Institute at NCH
Are You a Good Fit for This Trial?
This trial is for young people aged 12-17 who are at risk of suicide and receive care at one of the participating primary care clinics. It includes those with or without mental health issues, as well as those with physical illnesses or on medication, provided they meet other study criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
TAU (Treatment As Usual)
Participants receive usual and customary care, establishing baseline rates of suicide risk screening and detection
Intervention
Implementation of the STARRS-PC clinical pathway, including universal screening and risk assessment for suicide
Sustainability
Sites work on maintaining or improving gains made during the intervention phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Stepped Approach to Reducing Risk of Suicide in Primary Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cynthia Fontanella
Lead Sponsor
Holzer Gallipolis
Collaborator
Holzer Jackson
Collaborator
Holzer Athens
Collaborator
Eastglen Pediatrics
Collaborator
Signature Health Ashtabula
Collaborator
Signature Health Willoughby
Collaborator
Signature Health Painesville
Collaborator
AxessPointe - Arlington
Collaborator
Dayton Children's Hospital
Collaborator